Skip to content

Title 26 — Internal Revenue Code

Chapter 32 — Manufacturers Excise Taxes

§ 4132. Definitions and special rules

Statutory text

(a)

Definitions relating to taxable vaccines

For purposes of this subchapter—

(1)

Taxable vaccine

The term “taxable vaccine” means any of the following vaccines which are manufactured or produced in the United States or entered into the United States for consumption, use, or warehousing:

(A)

Any vaccine containing diphtheria toxoid.

(B)

Any vaccine containing tetanus toxoid.

(C)

Any vaccine containing pertussis bacteria, extracted or partial cell bacteria, or specific pertussis antigens.

(D)

Any vaccine against measles.

(E)

Any vaccine against mumps.

(F)

Any vaccine against rubella.

(G)

Any vaccine containing polio virus.

(H)

Any HIB vaccine.

(I)

Any vaccine against hepatitis A.

(J)

Any vaccine against hepatitis B.

(K)

Any vaccine against chicken pox.

(L)

Any vaccine against rotavirus gastroenteritis.

(M)

Any conjugate vaccine against streptococcus pneumoniae.

(N)

Any trivalent vaccine against influenza or any other vaccine against seasonal influenza.

(O)

Any meningococcal vaccine.

(P)

Any vaccine against the human papillomavirus.

(2)

Vaccine

The term “vaccine” means any substance designed to be administered to a human being for the prevention of 1 or more diseases.

(3)

United States

The term “United States” has the meaning given such term by section 4612(a)(4).

(4)

Importer

The term “importer” means the person entering the vaccine for consumption, use, or warehousing.

(b)

Credit or refund where vaccine returned to manufacturer, etc., or destroyed

(1)

In general

Under regulations prescribed by the Secretary, whenever any vaccine on which tax was imposed by section 4131 is—

(A)

returned (other than for resale) to the person who paid such tax, or

(B)

destroyed,

the Secretary shall abate such tax or allow a credit, or pay a refund (without interest), to such person equal to the tax paid under section 4131 with respect to such vaccine.

(2)

Claim must be filed within 6 months

Paragraph (1) shall apply to any returned or destroyed vaccine only with respect to claims filed within 6 months after the date the vaccine is returned or destroyed.

(3)

Condition of allowance of credit or refund

No credit or refund shall be allowed or made under paragraph (1) with respect to any vaccine unless the person who paid the tax establishes that he—

(A)

has repaid or agreed to repay the amount of the tax to the ultimate purchaser of the vaccine, or

(B)

has obtained the written consent of such purchaser to the allowance of the credit or the making of the refund.

(4)

Tax imposed only once

No tax shall be imposed by section 4131 on the sale of any vaccine if tax was imposed by section 4131 on any prior sale of such vaccine and such tax is not abated, credited, or refunded.

(c)

Other special rules

(1)

Certain uses treated as sales

Any manufacturer, producer, or importer of a vaccine which uses such vaccine before it is sold shall be liable for the tax imposed by section 4131 in the same manner as if such vaccine were sold by such manufacturer, producer, or importer.

(2)

Treatment of vaccines shipped to United States possessions

Section 4221(a)(2) shall not apply to any vaccine shipped to a possession of the United States.

(3)

Fractional part of a dose

In the case of a fraction of a dose, the tax imposed by section 4131 shall be the same fraction of the amount of such tax imposed by a whole dose.

(4)

Disposition of revenues from Puerto Rico and the Virgin Islands

The provisions of subsections (a)(3) and (b)(3) of section 7652 shall not apply to any tax imposed by section 4131.

Legislative history

Reconstructed from this section’s Code source credit and amendment notes, resolved against the local Statutes at Large. Editorial notes are evidence, not the law that made the change.

  1. Pub. L. 100–203 title IX § 9201(a) · 101 Stat. 1330

    Enacted · 26 U.S.C. § 4132

    Added Pub. L. 100–203, title IX, § 9201(a), Dec. 22, 1987, 101 Stat. 1330–329

    Source evidence

    Code source credit
    Added Pub. L. 100–203, title IX, § 9201(a), Dec. 22, 1987, 101 Stat. 1330–329

    Enacted provision · exact public law section
    (a) In General.— Chapter 32 of the Internal Revenue Code of 1986 (relating to manufacturers excise taxes) is amended by inserting after subchapter B the following new subchapter: “Subchapter C— Certain Vaccines “Sec. 4131. Imposition of tax. “Sec. 4132. Definitions and special rules. “SEC. 4131. IMPOSITION OF TAX. “(a) General Rule.— There is hereby imposed a tax on any taxable vaccine sold by the manufacturer, producer, or importer thereof. “(b) Amount of Tax.— “(1) In General.— The amount of the tax imposed by subsecretion (a) shall be determined in accordance with the following table: “If the taxable vaccine is: The tax per dose is: DPT vaccine ............................... $4.56 DT vaccine ............................... 0.06 MMR vaccine ............................... 4.44 Polio vaccine ............................... 0.29 “(2) Combinations of vaccines.— If any taxable vaccine is included in more than 1 category of vaccines in the table contained in paragraph (1), the amount of the tax imposed by subsection (a) on such vaccine shall be the sum of the amounts determined under such table for each category in which such vaccine is so included. “(c) Termination of Tax if Amounts Collected Exceed Projected Fund Liability.— “(1) In general.— If the Secretary estimates under paragraph (3) that the Vaccine Injury Compensation Trust Fund would not have a negative projected balance were the tax imposed by this section to terminate as of the close of any applicable date, no tax shall be imposed by this section after such date. “(2) Applicable date.— For purposes of paragraph (1), the term ‘applicable date’ means— “(A) the close of any calendar quarter ending on or after December 31, 1992, and “(B) the 1st date on which petitions may not be filed under section 2111 and 2111(a) of the Public Health Service reason of section 2134 of such Act and each date thereafter. “(3) Estimates by secretary.— “(A) In general.— The Secretary shall estimate the projected balance of the Vaccine Injury Compensation Trust Fund as of— “(i) the close of each calendar quarter ending on or after December 31, 1992, and “(ii) such other times as are appropriate in the case of applicable dates described in paragraph (2)(B). “(B) Determination of projected balance.— In determining the projected balance of the Fund as of any date, the Secretary shall assume that— “(i) the tax imposed by this section will not apply a after such date, and “(ii) there shall be paid from such Trust Fund all claims made or to be made against such Trust Fund— “(I) with respect to vaccines administered before October 1, 1992, in the case of an applicable date described in paragraph (2)(A), or “(II) with respect to petitions filed under section 2111 or section 2111(a) of the Public Health Service Act, in the case of an applicable date described in paragraph (2)(B). “SEC. 4132. DEFINITIONS AND SPECIAL RULES. “(a) Definitions Relating to Taxable Vaccines.— For purposes of this subchapter— “(1) Taxable vaccine.— The term ‘taxable vaccine’ means any vaccine— “(A) which is listed in the table contained in section 4131(b)(1), and “(B) which is manufactured or produced in the United States or entered into the United States for consumption, use, or warehousing. “(2) DPT vaccine.— The term ‘DPT vaccine’ means any vaccine containing pertussis bacteria, extracted or partial cell bacteria, or specific pertussis antigens. “(3) DT vaccine.— The term ‘DT vaccine’ means any vaccine (other than a DPT vaccine) containing diphtheria toxoid or tetanus toxoid. “(4) MMR vaccine.— The term “MMR vaccine” means any vaccine against measles, mumps, or rubella. Not more than 1 tax shall be imposed by section 4131 on any MMR vaccine by reason of being a vaccine against more than 1 of measles, mumps, or rubella. “(5) Polio vaccine.— The term ‘polio vaccine’ means any vaccine containing polio virus. “(6) Vaccine.— The term ‘vaccine’ means any substance designed to be administered to a human being for the prevention of 1 or more diseases. “(7) United states.— The term ‘United States’ has the meaning given such term by section 4612(a)(4). “(8) Importer.— The term ‘importer’ means the person entering the vaccine for consumption, use, or warehousing. “(b) Credit or Refund Where Vaccine Returned to Manufacturer, Etc., or Destroyed.— “(1) In general.— Under regulations prescribed by the Secretary, whenever any vaccine on which tax was imposed by section 4131 is— “(A) returned (other than for resale) to the person who paid such tax, or “(B) destroyed, the Secretary shall abate such tax or allow a credit, or pay a refund (without interest), to such person equal to the tax paid under section 4131 with respect to such vaccine. “(2) Claim must be filed within 6 months.— Paragraph (1) shall apply to any returned or destroyed vaccine only with respect to claims filed within 6 months after the date the vaccine is returned or destroyed. “(3) Condition of allowance of credit or refund.— No credit or refund shall be allowed or made under paragraph (1) with respect to any vaccine unless the person who paid the tax establishes that he— “(A) has repaid or agreed to repay the amount of the tax to the ultimate purchaser of the vaccine, or “(B) has obtained the written consent of such purchaser to the allowance of the credit or the making of the refund. “(4) Tax imposed only once.— No tax shall be imposed by section 4131 on the sale of any vaccine if tax was imposed by section 4131 on any prior sale of such vaccine and such tax is not abated, credited, or refunded. “(c) Other Special Rules.— “(1) Fractional part of a dose.— In the case of a fraction of a dose, the tax imposed by section 4131 shall be the same fraction of the amount of such tax imposed by a whole dose. “(2) Disposition of revenues from puerto rico and the virgin islands.— The provisions of subsections (a)(3) and (b)(3) of section 7652 shall not apply to any tax imposed by section 4131.”

  2. Technical and Miscellaneous Revenue Act of 1988

    Pub. L. 100–647 title II § 2006(a) · 102 Stat. 3342

    1. Added · 26 U.S.C. § 4132(c)

      Pub. L. 100–647 added pars. (1) and (2)

    2. Redesignated · 26 U.S.C. § 4132(c)

      Pub. L. 100–647 redesignated former pars. (1) and (2) as (3) and (4), respectively

    Source evidence

    Code amendment note
    Subsec. (c). Pub. L. 100–647 added pars. (1) and (2) and redesignated former pars. (1) and (2) as (3) and (4), respectively.

    Enacted provision · exact public law section
    (a) Subsection (c) of section 4132 of the 1986 Code (relating to imposition of tax on certain vaccines) is amended by redesignating paragraphs (1) and (2) as paragraphs (3) and (4), respectively, and by inserting before paragraph (3) (as so redesignated) the following new paragraphs: “(1) Certain uses treated as sales.— Any manufacturer, producer, or importer of a vaccine which uses such vaccine before it is sold shall be liable for the tax imposed by section 4131 in the same manner as if such vaccine were sold by such manufacturer, producer, or importer. “(2) Treatment of vaccines shipped to united states possessions.— Section 4221(a)(2) shall not apply to any vaccine shipped to a possession of the United States.”

  3. Pub. L. 105–34 § 904(b) · 111 Stat. 788

    Amended · 26 U.S.C. § 4132(a)(1)

    Pub. L. 105–34, § 904(b), amended heading and text of par. (1) generally. Prior to amendment, text read as follows: “The term ‘taxable vaccine’ means any vaccine—

    Source evidence

    Code amendment note
    Subsec. (a)(1). Pub. L. 105–34, § 904(b), amended heading and text of par. (1) generally. Prior to amendment, text read as follows: “The term ‘taxable vaccine’ means any vaccine—

    “(A) which is listed in the table contained in section 4131(b)(1), and “(B) which is manufactured or produced in the United States or entered into the United States for consumption, use, or warehousing.”

    Enacted provision · exact public law section
    (b) Taxable Vaccines.— Paragraph (1) of section 4132(a) is amended to read as follows: “(1) Taxable vaccine.— The term ‘taxable vaccine’ means any of the following vaccines which are manufactured or produced in the United States or entered into the United States for consumption, use, or warehousing: “(A) Any vaccine containing diphtheria toxoid. “(B) Any vaccine containing tetanus toxoid. “(C) Any vaccine containing pertussis bacteria, extracted or partial cell bacteria, or specific pertussis antigens. “(D) Any vaccine against measles. “(E) Any vaccine against mumps. “(F) Any vaccine against rubella. “(G) Any vaccine containing polio virus. “(H) Any HIB vaccine. “(I) Any vaccine against hepatitis B. “(J) Any vaccine against chicken pox.”.

  4. Pub. L. 105–34 § 904(c) · 111 Stat. 788

    1. Redesignated · 26 U.S.C. § 4132(a)(2)(8)

      Pub. L. 105–34, § 904(c), redesignated pars. (6) to (8) as (2) to (4), respectively

    2. Struck · 26 U.S.C. § 4132(a)(2)(8)

      Pub. L. 105–34, § 904(c), struck out former pars. (2) to (5) which read as follows:

    Source evidence

    Code amendment note
    Subsec. (a)(2) to (8). Pub. L. 105–34, § 904(c), redesignated pars. (6) to (8) as (2) to (4), respectively, and struck out former pars. (2) to (5) which read as follows:

    “(2) DPT vaccine.—The term ‘DPT vaccine’ means any vaccine containing pertussis bacteria, extracted or partial cell bacteria, or specific pertussis antigens. “(3) DT vaccine.—The term ‘DT vaccine’ means any vaccine (other than a DPT vaccine) containing diphtheria toxoid or tetanus toxoid. “(4) MMR vaccine.—The term ‘MMR vaccine’ means any vaccine against measles, mumps, or rubella. Not more than 1 tax shall be imposed by section 4131 on any MMR vaccine by reason of being a vaccine against more than 1 of measles, mumps, or rubella. “(5) Polio vaccine.—The term ‘polio vaccine’ means any vaccine containing polio virus.”

    Enacted provision · exact public law section
    (c) Conforming Amendment.— Subsection (a) of section 4132 is amended by striking paragraphs (2), (3), (4), and (5) and by redesignating paragraphs (6) through (8) as paragraphs (2) through (4), respectively.

  5. Pub. L. 105–277 § 3002(a) · 112 Stat. 2681

    Added · 26 U.S.C. § 4132(a)(1)(K)

    Pub. L. 105–277, § 3002(a), added a subpar. (K) identical to that added by Pub. L. 105–277, § 1503(a). See below

    Source evidence

    Code amendment note
    Subsec. (a)(1)(K). Pub. L. 105–277, § 3002(a), added a subpar. (K) identical to that added by Pub. L. 105–277, § 1503(a). See below.

    Enacted provision · exact public law section
    (a) In General.— Paragraph (1) of section 4132(a) (defining taxable vaccine) is amended by adding at the end the following new subparagraph: “(K) Any vaccine against rotavirus gastroenteritis.”.

  6. Pub. L. 105–277 § 1503(a) · 112 Stat. 2681

    Repealed · 26 U.S.C. § 4132(a)(1)(K)

    Pub. L. 105–277, § 1503(a), which directed amendment of section 4132(1) by adding a new subpar. (K) at the end, was repealed by Pub. L. 106–170, § 523(b)(1)

    Target inherited from the preceding amendment note.

    Source evidence

    Code amendment note
    Pub. L. 105–277, § 1503(a), which directed amendment of section 4132(1) by adding a new subpar. (K) at the end, was repealed by Pub. L. 106–170, § 523(b)(1).

    Enacted provision · exact public law section
    (a) In General.— Section 4132(1) of the Internal Revenue Code 26 USC 4132. of 1986 (defining taxable vaccine) is amended by adding at the end the following new subparagraph: “(K) Any vaccine against rotavirus gastroenteritis.”.

  7. Tax Relief Extension Act of 1999

    Pub. L. 106–170 § 523(b)(1) · 113 Stat. 1860

    Repealed · 26 U.S.C. § 4132(a)(1)(K)

    Pub. L. 106–170, § 523(b)(1), repealed Pub. L. 105–277, § 1503(a). See 1998 Amendment note below

    Source evidence

    Code amendment note
    Subsec. (a)(1)(K). Pub. L. 106–170, § 523(b)(1), repealed Pub. L. 105–277, § 1503(a). See 1998 Amendment note below.

    Enacted provision · exact public law section
    (1) Sections 1503 and 1504 of the Vaccine Injury Compensation Program Modification Act (and the amendments made 26 USC 4132 and note, 9510 and note. by such sections) are hereby repealed.

  8. Tax Relief Extension Act of 1999

    Pub. L. 106–170 § 523(a)(1) · 113 Stat. 1860

    Added · 26 U.S.C. § 4132(a)(1)(L)

    Pub. L. 106–170, § 523(a)(1), added subpar. (L)

    Source evidence

    Code amendment note
    Subsec. (a)(1)(L). Pub. L. 106–170, § 523(a)(1), added subpar. (L).

    Enacted provision · exact public law section
    (1) In general.— Section 4132(a)(1) of the Internal Revenue Code of 1986 (defining taxable vaccine) is amended by adding 26 USC 4132. at the end the following new subparagraph: “(L) Any conjugate vaccine against streptococcus pneumoniae.” .

  9. Pub. L. 108–357 § 889(a) · 118 Stat. 1418

    1. Added · 26 U.S.C. § 4132(a)(1)(I)(M)

      Pub. L. 108–357, § 889(a), added subpar. (I)

    2. Redesignated · 26 U.S.C. § 4132(a)(1)(I)(M)

      Pub. L. 108–357, § 889(a), redesignated former subpars. (I) to (L) as (J) to (M), respectively

    Source evidence

    Code amendment note
    Subsec. (a)(1)(I) to (M). Pub. L. 108–357, § 889(a), added subpar. (I) and redesignated former subpars. (I) to (L) as (J) to (M), respectively.

    Enacted provision · exact public law section
    (a) In General.— Paragraph (1) of section 4132(a) (defining taxable vaccine) is amended by redesignating subparagraphs (I), (J), (K), and (L) as subparagraphs (J), (K), (L), and (M), respectively, and by inserting after subparagraph (H) the following new subparagraph: “(I) Any vaccine against hepatitis A.” .

  10. Pub. L. 108–357 § 890(a) · 118 Stat. 1418

    Added · 26 U.S.C. § 4132(a)(1)(N)

    Pub. L. 108–357, § 890(a), added subpar. (N)

    Source evidence

    Code amendment note
    Subsec. (a)(1)(N). Pub. L. 108–357, § 890(a), added subpar. (N).

    Enacted provision · exact public law section
    (a) In General.— Section 4132(a)(1) (defining taxable vaccine), as amended by this Act, is amended by adding at the end the following new subparagraph: “(N) Any trivalent vaccine against influenza.” .

  11. Tax Relief and Health Care Act of 2006

    Pub. L. 109–432 div. A title IV § 408(a) · 120 Stat. 2922

    Added · 26 U.S.C. § 4132(a)(1)(O); 26 U.S.C. § 4132(a)(1)(P)

    Pub. L. 109–432 added subpars. (O) and (P)

    Source evidence

    Code amendment note
    Subsec. (a)(1)(O), (P). Pub. L. 109–432 added subpars. (O) and (P).

    Enacted provision · exact public law section
    (a) Meningococcal Vaccine.— Section 4132(a)(1) (defining taxable vaccine) is amended by adding at the end the following new subparagraph: “(O) Any meningococcal vaccine.” .

  12. Pub. L. 113–15 § 1(a) · 127 Stat. 476

    Inserted · 26 U.S.C. § 4132(a)(1)(N)

    Pub. L. 113–15 inserted “or any other vaccine against seasonal influenza” before period at end

    Source evidence

    Code amendment note
    Subsec. (a)(1)(N). Pub. L. 113–15 inserted “or any other vaccine against seasonal influenza” before period at end.

    Enacted provision · exact public law section
    (a) In General.— Subparagraph (N) of section 4132(a)(1) of the Internal Revenue Code of 1986 26 USC 4132. is amended by inserting “or any other vaccine against seasonal influenza” before the period.

    Effective date note
    Pub. L. 113–15, § 1(b), June 25, 2013, 127 Stat. 476, provided that:

15 of 15 references resolved to an enrolled provision

Editorial Notes

Amendments1988–2013 · 7 rounds

2013

Subsec. (a)(1)(N). Pub. L. 113–15 inserted “or any other vaccine against seasonal influenza” before period at end.

2006

Subsec. (a)(1)(O), (P). Pub. L. 109–432 added subpars. (O) and (P).

2004

Subsec. (a)(1)(I) to (M). Pub. L. 108–357, § 889(a), added subpar. (I) and redesignated former subpars. (I) to (L) as (J) to (M), respectively.

Subsec. (a)(1)(N). Pub. L. 108–357, § 890(a), added subpar. (N).

1999

Subsec. (a)(1)(K). Pub. L. 106–170, § 523(b)(1), repealed Pub. L. 105–277, § 1503(a). See 1998 Amendment note below.

Subsec. (a)(1)(L). Pub. L. 106–170, § 523(a)(1), added subpar. (L).

1998

Subsec. (a)(1)(K). Pub. L. 105–277, § 3002(a), added a subpar. (K) identical to that added by Pub. L. 105–277, § 1503(a). See below.

Pub. L. 105–277, § 1503(a), which directed amendment of section 4132(1) by adding a new subpar. (K) at the end, was repealed by Pub. L. 106–170, § 523(b)(1).

1997

Subsec. (a)(1). Pub. L. 105–34, § 904(b), amended heading and text of par. (1) generally. Prior to amendment, text read as follows: “The term ‘taxable vaccine’ means any vaccine—

“(A) which is listed in the table contained in section 4131(b)(1), and

“(B) which is manufactured or produced in the United States or entered into the United States for consumption, use, or warehousing.”

Subsec. (a)(2) to (8). Pub. L. 105–34, § 904(c), redesignated pars. (6) to (8) as (2) to (4), respectively, and struck out former pars. (2) to (5) which read as follows:

“(2) DPT vaccine.—The term ‘DPT vaccine’ means any vaccine containing pertussis bacteria, extracted or partial cell bacteria, or specific pertussis antigens.

“(3) DT vaccine.—The term ‘DT vaccine’ means any vaccine (other than a DPT vaccine) containing diphtheria toxoid or tetanus toxoid.

“(4) MMR vaccine.—The term ‘MMR vaccine’ means any vaccine against measles, mumps, or rubella. Not more than 1 tax shall be imposed by section 4131 on any MMR vaccine by reason of being a vaccine against more than 1 of measles, mumps, or rubella.

“(5) Polio vaccine.—The term ‘polio vaccine’ means any vaccine containing polio virus.”

1988

Subsec. (c). Pub. L. 100–647 added pars. (1) and (2) and redesignated former pars. (1) and (2) as (3) and (4), respectively.

Statutory Notes and Related Subsidiaries

Effective Date of 2013 Amendment

Pub. L. 113–15, § 1(b), , 127 Stat. 476, provided that:

“(1)

Sales, etc.—

The amendment made by this section [amending this section] shall apply to sales and uses on or after the later of—

“(A)

the first day of the first month which begins more than 4 weeks after the date of the enactment of this Act [], or

“(B)

the date on which the Secretary of Health and Human Services lists any vaccine against seasonal influenza (other than any vaccine against seasonal influenza listed by the Secretary prior to the date of the enactment of this Act) for purposes of compensation for any vaccine-related injury or death through the Vaccine Injury Compensation Trust Fund.

“(2)

Deliveries.—

For purposes of paragraph (1) and section 4131 of the Internal Revenue Code of 1986, in the case of sales on or before the effective date described in such paragraph for which delivery is made after such date, the delivery date shall be considered the sale date.”

Effective Date of 2006 Amendment

Pub. L. 109–432, div. A, title IV, § 408(c), , 120 Stat. 2962, provided that:

“(1)

Sales, etc.—

The amendments made by this section [amending this section] shall apply to sales and uses on or after the first day of the first month which begins more than 4 weeks after the date of the enactment of this Act [].

“(2)

Deliveries.—

For purposes of paragraph (1) and section 4131 of the Internal Revenue Code of 1986, in the case of sales on or before the effective date described in such paragraph for which delivery is made after such date, the delivery date shall be considered the sale date.”

Effective Date of 2004 Amendment

Pub. L. 108–357, title VIII, § 889(b), , 118 Stat. 1643, provided that:

“(1)

Sales, etc.—

The amendments made by subsection (a) [amending this section] shall apply to sales and uses on or after the first day of the first month which begins more than 4 weeks after the date of the enactment of this Act [].

“(2)

Deliveries.—

For purposes of paragraph (1) and section 4131 of the Internal Revenue Code of 1986, in the case of sales on or before the effective date described in such paragraph for which delivery is made after such date, the delivery date shall be considered the sale date.”

Pub. L. 108–357, title VIII, § 890(b), , 118 Stat. 1644, provided that:

“(1)

Sales, etc.—

The amendment made by this section [amending this section] shall apply to sales and uses on or after the later of—

“(A)

the first day of the first month which begins more than 4 weeks after the date of the enactment of this Act [], or

“(B)

the date on which the Secretary of Health and Human Services lists any vaccine against influenza for purposes of compensation for any vaccine-related injury or death through the Vaccine Injury Compensation Trust Fund.

“(2)

Deliveries.—

For purposes of paragraph (1) and section 4131 of the Internal Revenue Code of 1986, in the case of sales on or before the effective date described in such paragraph for which delivery is made after such date, the delivery date shall be considered the sale date.”

Effective Date of 1999 Amendment

Pub. L. 106–170, title V, § 523(a)(2), , 113 Stat. 1927, provided that:

“(A)

Sales.—

The amendment made by this subsection [amending this section] shall apply to vaccine sales after the date of the enactment of this Act [], but shall not take effect if subsection (b) [see note below] does not take effect.

“(B)

Deliveries.—

For purposes of subparagraph (A), in the case of sales on or before the date described in such subparagraph for which delivery is made after such date, the delivery date shall be considered the sale date.”

Pub. L. 106–170, title V, § 523(b)(3), , 113 Stat. 1928, provided that: “The amendments made by this subsection [amending this section and section 9510 of this title and repealing provisions set out as notes under this section and section 9510 of this title] shall take effect as if included in the provisions of the Omnibus Consolidated and Emergency Supplemental Appropriations Act, 1999 [Pub. L. 105–277] to which they relate.”

Effective Date of 1998 Amendment

Pub. L. 105–277, div. C, title XV, § 1503(b), div. I, title III, § 3002(b), , 112 Stat. 2681–741, 2681–905, which provided that amendment of this section by Pub. L. 105–277 was applicable to sales after , and that delivery date would be considered sale date in the case of sales on or before , was repealed by Pub. L. 106–170, title V, § 523(b)(1), , 113 Stat. 1927.

Effective Date of 1997 Amendment

Amendment by Pub. L. 105–34 effective on the day after , see section 904(d) of Pub. L. 105–34, set out as a note under section 4131 of this title.

Effective Date of 1988 Amendment

Pub. L. 100–647, title II, § 2006(c), , 102 Stat. 3613, provided that: “The amendments made by this section [amending this section and section 9510 of this title] shall take effect as if included in the amendments made by section 9201 of the Omnibus Budget Reconciliation Act of 1987 [Pub. L. 100–203].”

Limitation on Certain Credits or Refunds

Pub. L. 105–34, title IX, § 904(e), , 111 Stat. 874, provided that: “For purposes of applying section 4132(b) of the Internal Revenue Code of 1986 with respect to any claim for credit or refund filed before , the amount of tax taken into account shall not exceed the tax computed under the rate in effect on the day after the date of the enactment of this Act [].”

Credits

1987–2013 · 8 acts
  1. 1987Added Pub. L. 100–203, title IX, § 9201(a), , 101 Stat. 1330–329
  2. 1988amended Pub. L. 100–647, title II, § 2006(a), , 102 Stat. 3612
  3. 1997Pub. L. 105–34, title IX, § 904(b), (c), , 111 Stat. 873, 874
  4. 1998Pub. L. 105–277, div. C, title XV, § 1503(a), div. J, title III, § 3002(a), , 112 Stat. 2681–741, 2681–905
  5. 1999Pub. L. 106–170, title V, § 523(a)(1), (b)(1), , 113 Stat. 1927
  6. 2004Pub. L. 108–357, title VIII, §§ 889(a), 890(a), , 118 Stat. 1643, 1644
  7. 2006Pub. L. 109–432, div. A, title IV, § 408(a), (b), , 120 Stat. 2962
  8. 2013Pub. L. 113–15, § 1(a), , 127 Stat. 476.
Show as published

(Added Pub. L. 100–203, title IX, § 9201(a), , 101 Stat. 1330–329; amended Pub. L. 100–647, title II, § 2006(a), , 102 Stat. 3612; Pub. L. 105–34, title IX, § 904(b), (c), , 111 Stat. 873, 874; Pub. L. 105–277, div. C, title XV, § 1503(a), div. J, title III, § 3002(a), , 112 Stat. 2681–741, 2681–905; Pub. L. 106–170, title V, § 523(a)(1), (b)(1), , 113 Stat. 1927; Pub. L. 108–357, title VIII, §§ 889(a), 890(a), , 118 Stat. 1643, 1644; Pub. L. 109–432, div. A, title IV, § 408(a), (b), , 120 Stat. 2962; Pub. L. 113–15, § 1(a), , 127 Stat. 476.)

Parsed from the official OLRC USLM XML in data/usc_all/usc26.xml · release point 119-108 · OLRC build 2026-09-16

USLM identifier /us/usc/t26/s4132